Cover
Cover | Mar. 17, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Mar. 17, 2022 |
Entity File Number | 001-38356 |
Entity Registrant Name | VYNE Therapeutics Inc. |
Entity Central Index Key | 0001566044 |
Entity Tax Identification Number | 45-3757789 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 520 U.S. Highway 22 |
Entity Address, Address Line Two | Suite 204 |
Entity Address, City or Town | Bridgewater |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 08807 |
City Area Code | 800 |
Local Phone Number | 775-7936 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.0001 par value |
Trading Symbol | VYNE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |